SCHEMBL31702241

SCHEMBL31702241

CNc1ccc(C2CCN(C(=O)OC(C)(C)C)CC2(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN6 P29350 1/20 0.47
NAMPT P43490 1/20 0.46
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GPR119 Q8TDV5 4/20 0.43
STS P08842 2/20 0.43
ABL1 P00519 1/20 0.42
RIN1 Q13671 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
RORC P51449 6/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16611368 0.87 RORC (0.43) PTPN2PTPN1PTPN6GPR119STS
SCHEMBL30726423 0.86 RORC (0.55) PTPN2PTPN1PTPN6GPR119STS
SCHEMBL23538696 0.86 ALDH1A1 (0.44) PTPN2PTPN1PTPN6ALDH1A1NPC1
SCHEMBL23291509 0.86 RORC (0.55) PTPN2PTPN1PTPN6GPR119STS
SCHEMBL35211565 0.86 STS (0.52) GPR119STSRORC
SCHEMBL22551229 0.85 KMT2A (0.43) PTPN2PTPN1PTPN6NAMPTALDH1A1
SCHEMBL16874573 0.85 ALDH1A1 (0.55) ALDH1A1MAPTHTTGPR119STS
SCHEMBL16874571 0.85 ALDH1A1 (0.55) ALDH1A1MAPTHTTGPR119STS
SCHEMBL23538342 0.82 ALDH1A1 (0.54) ALDH1A1MAPTGPR119STSRORC
SCHEMBL31700556 0.82 GPR119 (0.52) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014147-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2026-01-15 US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed
US-20250320205-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 PTPN2 693/4885PTPN1 789/4885PTPN6 497/4885
US-20250320205-A1 STAT6 DEGRADERS STAT6, STAT1, STAT5B PTPN2 569/4885PTPN1 675/4885PTPN6 447/4885
US-20260014147-A1 STAT6 DEGRADERS STAT6, NCOR1, CBR1 PTPN2 423/4885PTPN1 232/4885PTPN6 411/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 PTPN2 693/4885PTPN1 789/4885PTPN6 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.